More on CADL

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.1 Score)

Upcoming Events

- Earnings (5/8/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Candel Therapeutics (NQ:CADL)
Delayed: 4.94 +0.09 (1.86%)
Prev. Close $4.85  
Open$4.72 
52 Wk High$ 
52 Wk Low$ 
Day High$5.00 
Day Low$4.65 
P/E N/A  
EPS$ 
Volume1,006,397 

Friends, Peers and Foes (?): TRIN (more...)

Mar 2, 2026 04:05 PM Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 26, 2026 07:39 PM Form 4 Candel Therapeutics, For: Feb 23 Filed by: Manning Paul B
Feb 24, 2026 08:05 AM Candel Therapeutics to Present at TD Cowen’s 46th Annual Health Care Conference in Boston
Feb 23, 2026 08:01 AM Form 8-K Candel Therapeutics, For: Feb 19
Feb 20, 2026 04:16 PM Form 424B5 Candel Therapeutics,
Feb 19, 2026 09:40 PM Candel Therapeutics prices $100 million public offering at $5.45 per share
Feb 19, 2026 09:40 PM Candel Therapeutics Announces Pricing of Public Offering
Feb 19, 2026 04:32 PM Form 424B5 Candel Therapeutics,
Feb 19, 2026 04:05 PM Candel Therapeutics launches $100 million public offering
Feb 19, 2026 04:05 PM Candel Therapeutics Announces Proposed $100 Million Public Offering
View All Articles

Entities mentioned with CADL

View All Entities